An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer
This study has been completed.
Sponsor:
Epimmune
Information provided by:
Epimmune
ClinicalTrials.gov Identifier:
NCT00054899
First received: February 12, 2003
Last updated: March 23, 2010
Last verified: April 2004
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |